Insulin-treated diabetes is not associated with increased mortality in critically ill patients

Critical Care

Volumn 14, Issue 1, 2010, Pages

  Vincent, Jean Louis ^a   Preiser, Jean Charles ^b   Sprung, Charles L ^c   Moreno, Rui ^d   Sakr, Yasser ^e  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d HOSPITAL DE SANTO ANTÓNIO DOS CAPUCHOS   (Portugal)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; COHORT ANALYSIS; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; HEMODIALYSIS; HEMOFILTRATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MORBIDITY; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIMPLIFIED ACUTE PHYSIOLOGY SYSTEM II SCORE; TREATMENT OUTCOME; CLINICAL TRIAL; CRITICAL ILLNESS; EUROPE; LENGTH OF STAY;

ADULT; COHORT STUDIES; CRITICAL ILLNESS; DIABETES MELLITUS; EUROPE; HOSPITAL MORTALITY; HUMANS; INSULIN; LENGTH OF STAY;

EID: 77956621299     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8866     Document Type: Article

References (49)

1. International Diabetes Federation Diabetes Atlas. 2006, Brussels: International Diabetes Federation, 3, International Diabetes Federation.
2. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989, 38:1031-1035. 10.2337/diabetes.38.8.1031, 2753233.
3. Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 1995, 123:919-924.
4. Kjersem H, Hilsted J, Madsbad S, Wandall JH, Johansen KS, Borregaard N. Polymorphonuclear leucocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type 1 (insulin dependent) diabetic patients. Infection 1988, 16:215-221. 10.1007/BF01650754, 2846445.
5. Rassias AJ, Givan AL, Marrin CA, Whalen K, Pahl J, Yeager MP. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg 2002, 94:1113-1119. table, 10.1097/00000539-200205000-00010, 11973171.
6. Sreeramoju PV, Tolentino J, Garcia-Houchins S, Weber SG. Predictive factors for the development of central line-associated bloodstream infection due to gram-negative bacteria in intensive care unit patients after surgery. Infect Control Hosp Epidemiol 2008, 29:51-56. 10.1086/524334, 18171187.
7. Bochicchio GV, Joshi M, Bochicchio K, Shih D, Meyer W, Scalea TM. Incidence and impact of risk factors in critically ill trauma patients. World J Surg 2006, 30:114-118. 10.1007/s00268-005-0203-x, 16369714.
8. Bucerius J, Gummert JF, Walther T, Doll N, Falk V, Onnasch JF, Barten MJ, Mohr FW. Impact of diabetes mellitus on cardiac surgery outcome. Thorac Cardiovasc Surg 2003, 51:11-16. 10.1055/s-2003-37280, 12587082.
9. McCampbell B, Wasif N, Rabbitts A, Staiano-Coico L, Yurt RW, Schwartz S. Diabetes and burns: retrospective cohort study. J Burn Care Rehabil 2002, 23:157-166. 10.1097/00004630-200205000-00004, 12032365.
10. Ahmad R, Cherry RA, Lendel I, Mauger DT, Service SL, Texter LJ, Gabbay RA. Increased hospital morbidity among trauma patients with diabetes mellitus compared with age- and injury severity score-matched control subjects. Arch Surg 2007, 142:613-618. 10.1001/archsurg.142.7.613, 17638797.
11. Brown JR, Edwards FH, O'Connor GT, Ross CS, Furnary AP. The diabetic disadvantage: historical outcomes measures in diabetic patients undergoing cardiac surgery -- the pre-intravenous insulin era. Semin Thorac Cardiovasc Surg 2006, 18:281-288. 10.1053/j.semtcvs.2006.04.004, 17395023.
12. Vardakas KZ, Siempos II, Falagas ME. Diabetes mellitus as a risk factor for nosocomial pneumonia and associated mortality. Diabet Med 2007, 24:1168-1171. 10.1111/j.1464-5491.2007.02234.x, 17888136.
13. Pittet D, Thiévent B, Wenzel RP, Li N, Gurman G, Suter PM. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 1993, 19:265-272. 10.1007/BF01690546, 8408935.
14. Slynkova K, Mannino DM, Martin GS, Morehead RS, Doherty DE. The role of body mass index and diabetes in the development of acute organ failure and subsequent mortality in an observational cohort. Crit Care 2006, 10:R137. 1751063, 16999863, 10.1186/cc5051.
15. Ligtenberg JJ, Meijering S, Stienstra Y, van dH I, Vogelzang M, Nijsten MW, Tulleken JE, Zijlstra JG. Mean glucose level is not an independent risk factor for mortality in mixed ICU patients. Intensive Care Med 2006, 32:435-438. 10.1007/s00134-005-0052-y, 16477415.
16. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353. 10.1097/01.CCM.0000194725.48928.3A, 16424713.
17. Le Gall J-R, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.270.24.2957, 8254858.
18. Vincent JL, Moreno R, Takala J, Willatts S, de Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
19. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
20. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter P, Sprung C, Colardyn FC, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicentric, prospective study. Crit Care Med 1998, 26:1793-1800.
21. Guerin C, Girard R, Selli JM, Perdrix JP, Ayzac L. Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am J Respir Crit Care Med 2000, 161:872-879.
22. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006.
23. Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 2005, 128:3233-3239. 10.1378/chest.128.5.3233, 16304267.
24. Tsai CL, Lee CC, Ma MH, Fang CC, Chen SY, Chen WJ, Chang SC, Mehta SH. Impact of diabetes on mortality among patients with community-acquired bacteremia. J Infect 2007, 55:27-33. 10.1016/j.jinf.2007.01.004, 17349696.
25. Kvan E, Pettersen KI, Sandvik L, Reikvam A. High mortality in diabetic patients with acute myocardial infarction: cardiovascular co-morbidities contribute most to the high risk. Int J Cardiol 2007, 121:184-188. 10.1016/j.ijcard.2006.11.003, 17184858.
26. Ishihara M, Kagawa E, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nakama Y, Maruhashi T, Ookawa K, Dai K, Aokage Y. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 2007, 99:1674-1679. 10.1016/j.amjcard.2007.01.044, 17560874.
27. Kao LS, Todd SR, Moore FA. The impact of diabetes on outcome in traumatically injured patients: an analysis of the National Trauma Data Bank. Am J Surg 2006, 192:710-714. 10.1016/j.amjsurg.2006.08.031, 17161080.
28. Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, Gheorghiade M, O'Connor CM, Sun JL, Yancy CW, Young JB, Fonarow GC. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2007, 154:277-278.
29. Guckelberger O, Thelen A, Benckert C, Schoebel C, Reuter S, Klupp J, Jonas S, Neuhaus P. Diabetes mellitus is no independent risk factor for perioperative mortality following hepatic resection. Exp Clin Endocrinol Diabetes 2006, 114:257-261. 10.1055/s-2006-924234, 16804800.
30. Stegenga ME, Vincent JL, Vail GM, Williams MD, Bernard GR, Poll T. Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis [abstract]. Crit Care Med 2010, 38:539-545. 10.1007/s00011-006-0500-3, 19851093.
31. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002, 87:978-982. 10.1210/jc.87.3.978, 11889147.
32. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003, 290:2041-2047. 10.1001/jama.290.15.2041, 14559958.
33. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004, 79:992-1000. 10.4065/79.8.992, 15301325.
34. Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patient. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
35. Merz TM, Finfer S. Pro/con debate: Is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients?. Crit Care 2008, 12:212. 2447574, 18466639, 10.1186/cc6837.
36. Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006, 55:3151-3159. 10.2337/db06-0855, 17065355.
37. Devos P, Preiser JC. Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU?. Crit Care 2006, 10:130. 1550900, 16569259, 10.1186/cc4871.
38. Preiser JC, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med 2007, 35:S503-S507. 10.1097/01.CCM.0000278046.24345.C7, 17713400.
39. Booth G, Stalker TJ, Lefer AM, Scalia R. Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab 2001, 280:E848-E856.
40. Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461. 10.1056/NEJMoa052521, 16452557.
41. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc 2005, 80:1558-1567. 10.4065/80.12.1558, 16342648.
42. Whitcomb BW, Pradhan EK, Pittas AG, Roghmann MC, Perencevich EN. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 2005, 33:2772-2777. 10.1097/01.CCM.0000189741.44071.25, 16352959.
43. Krinsley JS. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital. Semin Thorac Cardiovasc Surg 2006, 18:317-325. 10.1053/j.semtcvs.2006.12.003, 17395028.
44. Stead LG, Gilmore RM, Bellolio MF, Mishra S, Bhagra A, Vaidyanathan L, Decker WW, Brown RD. Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke. Neurocrit Care 2009, 10(2):181-186. 10.1007/s12028-008-9080-0, 18357419.
45. Sleiman I, Morandi A, Sabatini T, Ranhoff A, Ricci A, Rozzini R, Trabucchi M. Hyperglycemia as a predictor of in-hospital mortality in elderly patients without diabetes mellitus Admitted to a Sub-Intensive Care Unit. J Am Geriatr Soc 2008, 56:1106-1110. 10.1111/j.1532-5415.2008.01729.x, 18482306.
46. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 2008, 36:2249-2255. 10.1097/CCM.0b013e318181039a, 18664780.
47. Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall JR. SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 2005, 31:1345-1355. 1315315, 16132892, 10.1007/s00134-005-2763-5.
48. Moss M, Guidot DM, Steinberg KP, Duhon GF, Treece P, Wolken R, Hudson LD, Parsons PE. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 2000, 28:2187-2192. 10.1097/00003246-200007000-00001, 10921539.
49. Iscimen R, Cartin-Ceba R, Yilmaz M, Khan H, Hubmayr RD, Afessa B, Gajic O. Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med 2008, 36:1518-1522. 10.1097/CCM.0b013e31816fc2c0, 18434908.